SUBGEN — Subgen AI AB Share News
0.000.00%
- SEK42.13m
- SEK277.56m
- SEK204.39m
Brief: Aegirbio, Dynamic Code Choose To Not Continue Discussions On Acquisition
Brief: Thailand Approves Covid-19 Aegirbio Test
Brief: Aegirbio Q2 Pretax Loss At SEK 12.5 Mln
Brief: Aegirbio Gets Order In Vietnam
Brief: Aegirbio Gets Order Of Over SEK 400 Million
Brief: Aegirbio Secures Production Capacity
Brief: Aegirbio: EPO Intends To Grant Patent
Brief: Aegirbio Gets SEK 100 Million Test Order
Brief: Aegirbio Prepares Change Of Listing To Nasdaq Stockholm Main List
Brief: Aegirbio: COVID-Test Approved In Germany By BfArM
Brief: Aegirbio Signs Agreement For Sale Of COVID-19 Tests In Germany
Brief: Aegirbio AB - Signs Distribution Agreement And Receives An Order
Brief: AegirBio Q4 Pretax Loss SEK 10.6 Mln
Brief: AegirBio Prelim FY Operating Loss At SEK 18.5 Mln
Brief: Aegirbio And Lifeassays Are Proposed To Be Merged
Brief: Aegirbio Gets Subsidy Of SEK 4.3 Mln From Eurostar
Brief: Aegirbio Q3 Pretax Loss At SEK 2.5 Mln
Brief: Aegirbio Starts FDA Fast Track Process With Its COVID-19 Test
Brief: Aegirbio's Covidtest Delivers Convincing Results In Italian And Swedish Studies